Additionally, exosomal PD-L1 expression levels are significantly correlated with tumour PDL-1 levels and can therefore be used as tool to evaluate the clinical efficacy of lung cancer immunotherapy [53,54,57]. This evidence concerns the gene CD274 and neoplasm.